The Gastrointestinal Infection Testing Panels Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Pathogen (Bacteria, Viruses, Parasites), By Test (Syndromic Full, Multiplex Panel, Low Plex Panel), By End-User (Hospitals, Diagnostic Laboratories, Others).
Rapid and accurate diagnosis of gastrointestinal infections is essential for guiding appropriate treatment and preventing the spread of infectious diseases. In 2024, gastrointestinal infection testing panels have emerged as indispensable tools in clinical microbiology laboratories, offering multiplex detection of bacterial, viral, and parasitic pathogens. These panels utilize molecular diagnostic techniques, such as polymerase chain reaction (PCR) and nucleic acid amplification, to deliver timely results with high sensitivity and specificity. With the ongoing threat of emerging infectious diseases and antimicrobial resistance, the demand for comprehensive testing panels capable of detecting a wide range of pathogens is expected to drive market growth in the years to come.
A notable trend in the market for gastrointestinal infection testing panels is the increasing adoption of multiplex testing panels for comprehensive diagnosis. With the complexity of gastrointestinal infections and the need for rapid and accurate identification of pathogens, there's a growing preference among healthcare providers for multiplex panels capable of detecting multiple infectious agents simultaneously. These advanced panels offer advantages such as improved sensitivity, specificity, and efficiency, enabling clinicians to promptly identify the causative agents of gastrointestinal infections and guide appropriate treatment decisions, ultimately leading to better patient outcomes.
The primary driver propelling the market for gastrointestinal infection testing panels is the escalating global burden of gastrointestinal infections and foodborne illnesses. With millions of cases reported annually worldwide, gastrointestinal infections pose a significant public health concern, leading to substantial morbidity, mortality, and economic burden. Factors such as contaminated food and water sources, poor sanitation, and increasing global travel contribute to the spread of gastrointestinal pathogens, driving the demand for rapid and reliable diagnostic tools like testing panels to identify infectious agents promptly, contain outbreaks, and prevent further transmission, thus addressing the critical need for effective infection control and public health management.
An untapped opportunity within the market for gastrointestinal infection testing panels lies in the expansion of point-of-care testing (POCT) solutions for rapid diagnosis. As the demand for timely diagnosis and treatment of gastrointestinal infections continues to rise, there's a growing need for portable, user-friendly testing devices that can deliver accurate results at the point of care, whether in clinical settings, remote locations, or resource-limited environments. By leveraging technological advancements in molecular diagnostics, microfluidics, and miniaturization, manufacturers have the opportunity to develop POCT platforms capable of detecting a broad range of gastrointestinal pathogens with high sensitivity and specificity, enabling early intervention, appropriate antimicrobial therapy, and improved patient management, particularly in settings where access to centralized laboratories may be limited. Embracing the potential of POCT solutions in gastrointestinal infection testing presents a promising opportunity to enhance healthcare delivery, reduce disease transmission, and mitigate the impact of gastrointestinal infections on public health.
The Multiplex Panel Testing segment within the Gastrointestinal Infection (GI) Testing Panels Market is experiencing rapid growth due to the increasing demand for comprehensive and efficient diagnostic solutions for gastrointestinal infections caused by bacteria, viruses, and parasites. Multiplex panel testing refers to the simultaneous detection and identification of multiple pathogens from a single clinical sample using molecular diagnostic techniques, such as polymerase chain reaction (PCR) or nucleic acid amplification tests (NAATs). These advanced testing panels offer several advantages over traditional culture-based methods, including higher sensitivity, faster turnaround times, and the ability to detect a broad range of pathogens in a single assay. Multiplex panels are designed to detect common gastrointestinal pathogens, including bacteria (such as Salmonella, Campylobacter, and Clostridium difficile), viruses (such as norovirus, rotavirus, and adenovirus), and parasites (such as Giardia and Cryptosporidium), allowing for comprehensive and accurate diagnosis of gastrointestinal infections with minimal sample volume and processing time. As gastrointestinal infections remain a significant public health concern worldwide, particularly in hospital settings and community outbreaks, there is a growing need for rapid and reliable diagnostic methods to identify and manage infectious agents effectively. Multiplex panel testing addresses this need by providing clinicians and laboratorians with valuable insights into the microbial etiology of gastrointestinal illnesses, enabling timely treatment decisions, infection control measures, and public health interventions. Moreover, the versatility and scalability of multiplex panel assays make them suitable for use in hospitals, diagnostic laboratories, and other healthcare settings, where they can streamline testing workflows, reduce healthcare costs, and improve patient outcomes. As healthcare providers increasingly prioritize the implementation of syndromic testing approaches and molecular diagnostic technologies for gastrointestinal infections, the Multiplex Panel Testing segment is poised for significant growth in the Gastrointestinal Infection (GI) Testing Panels Market, offering efficient and comprehensive solutions for disease detection and surveillance.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAnatolia Geneworks, ARUP Laboratories, Becton, Dickinson and Company, bioMérieux S.A., CerTest Biotec S.L., DiaSorin S.p.A., QIAGEN N.V., Quidel Corp, Savyon Diagnostics Ltd, Seegene Inc
By Pathogen
Bacteria
Viruses
Parasites
By Test
Syndromic Full
Multiplex Panel
Low Plex Panel
By End-User
Hospitals
Diagnostic Laboratories
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Anatolia Geneworks
ARUP Laboratories
Becton, Dickinson and Company
bioMérieux S.A.
CerTest Biotec S.L.
DiaSorin S.p.A.
QIAGEN N.V.
Quidel Corp
Savyon Diagnostics Ltd
Seegene Inc
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Gastrointestinal Infection Testing Panels Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Gastrointestinal Infection Testing Panels Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Gastrointestinal Infection Testing Panels Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Gastrointestinal Infection Testing Panels Market Size Outlook, $ Million, 2021 to 2030
3.2 Gastrointestinal Infection Testing Panels Market Outlook by Type, $ Million, 2021 to 2030
3.3 Gastrointestinal Infection Testing Panels Market Outlook by Product, $ Million, 2021 to 2030
3.4 Gastrointestinal Infection Testing Panels Market Outlook by Application, $ Million, 2021 to 2030
3.5 Gastrointestinal Infection Testing Panels Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Gastrointestinal Infection Testing Panels Industry
4.2 Key Market Trends in Gastrointestinal Infection Testing Panels Industry
4.3 Potential Opportunities in Gastrointestinal Infection Testing Panels Industry
4.4 Key Challenges in Gastrointestinal Infection Testing Panels Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Gastrointestinal Infection Testing Panels Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Gastrointestinal Infection Testing Panels Market Outlook by Segments
7.1 Gastrointestinal Infection Testing Panels Market Outlook by Segments, $ Million, 2021- 2030
By Pathogen
Bacteria
Viruses
Parasites
By Test
Syndromic Full
Multiplex Panel
Low Plex Panel
By End-User
Hospitals
Diagnostic Laboratories
Others
8 North America Gastrointestinal Infection Testing Panels Market Analysis and Outlook To 2030
8.1 Introduction to North America Gastrointestinal Infection Testing Panels Markets in 2024
8.2 North America Gastrointestinal Infection Testing Panels Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Gastrointestinal Infection Testing Panels Market size Outlook by Segments, 2021-2030
By Pathogen
Bacteria
Viruses
Parasites
By Test
Syndromic Full
Multiplex Panel
Low Plex Panel
By End-User
Hospitals
Diagnostic Laboratories
Others
9 Europe Gastrointestinal Infection Testing Panels Market Analysis and Outlook To 2030
9.1 Introduction to Europe Gastrointestinal Infection Testing Panels Markets in 2024
9.2 Europe Gastrointestinal Infection Testing Panels Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Gastrointestinal Infection Testing Panels Market Size Outlook by Segments, 2021-2030
By Pathogen
Bacteria
Viruses
Parasites
By Test
Syndromic Full
Multiplex Panel
Low Plex Panel
By End-User
Hospitals
Diagnostic Laboratories
Others
10 Asia Pacific Gastrointestinal Infection Testing Panels Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Gastrointestinal Infection Testing Panels Markets in 2024
10.2 Asia Pacific Gastrointestinal Infection Testing Panels Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Gastrointestinal Infection Testing Panels Market size Outlook by Segments, 2021-2030
By Pathogen
Bacteria
Viruses
Parasites
By Test
Syndromic Full
Multiplex Panel
Low Plex Panel
By End-User
Hospitals
Diagnostic Laboratories
Others
11 South America Gastrointestinal Infection Testing Panels Market Analysis and Outlook To 2030
11.1 Introduction to South America Gastrointestinal Infection Testing Panels Markets in 2024
11.2 South America Gastrointestinal Infection Testing Panels Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Gastrointestinal Infection Testing Panels Market size Outlook by Segments, 2021-2030
By Pathogen
Bacteria
Viruses
Parasites
By Test
Syndromic Full
Multiplex Panel
Low Plex Panel
By End-User
Hospitals
Diagnostic Laboratories
Others
12 Middle East and Africa Gastrointestinal Infection Testing Panels Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Gastrointestinal Infection Testing Panels Markets in 2024
12.2 Middle East and Africa Gastrointestinal Infection Testing Panels Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Gastrointestinal Infection Testing Panels Market size Outlook by Segments, 2021-2030
By Pathogen
Bacteria
Viruses
Parasites
By Test
Syndromic Full
Multiplex Panel
Low Plex Panel
By End-User
Hospitals
Diagnostic Laboratories
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Anatolia Geneworks
ARUP Laboratories
Becton, Dickinson and Company
bioMérieux S.A.
CerTest Biotec S.L.
DiaSorin S.p.A.
QIAGEN N.V.
Quidel Corp
Savyon Diagnostics Ltd
Seegene Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Pathogen
Bacteria
Viruses
Parasites
By Test
Syndromic Full
Multiplex Panel
Low Plex Panel
By End-User
Hospitals
Diagnostic Laboratories
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Gastrointestinal Infection Testing Panels Market is one of the lucrative growth markets, poised to register a 4.5% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Anatolia Geneworks, ARUP Laboratories, Becton, Dickinson and Company, bioMérieux S.A., CerTest Biotec S.L., DiaSorin S.p.A., QIAGEN N.V., Quidel Corp, Savyon Diagnostics Ltd, Seegene Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume